Arrowstreet Capital, Limited Partnership Gilead Sciences, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 2,996,669 shares of GILD stock, worth $271 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,996,669
Previous 4,585,204 34.64%
Holding current value
$271 Million
Previous $315 Million 20.16%
% of portfolio
0.21%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $106 Million - $133 Million
-1,588,535 Reduced 34.64%
2,996,669 $251 Million
Q2 2024

Aug 14, 2024
SELL
$63.15 - $72.88 $29.1 Million - $33.6 Million
-461,229 Reduced 9.14%
4,585,204 $315 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $239 Million - $291 Million
-3,331,941 Reduced 39.77%
5,046,433 $370 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $135 Million - $153 Million
-1,839,296 Reduced 18.0%
8,378,374 $679 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $98.4 Million - $107 Million
1,330,560 Added 14.97%
10,217,670 $766 Million
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $52.9 Million - $60.3 Million
695,909 Added 8.5%
8,887,110 $685 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $1.92 Million - $2.19 Million
-24,833 Reduced 0.3%
8,191,201 $680 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $238 Million - $342 Million
-3,820,541 Reduced 31.74%
8,216,034 $705 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $216 Million - $247 Million
-3,631,610 Reduced 23.18%
12,036,575 $743 Million
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $135 Million - $152 Million
-2,334,029 Reduced 12.97%
15,668,185 $968 Million
Q1 2022

May 13, 2022
BUY
$57.92 - $72.58 $797 Million - $999 Million
13,764,169 Added 324.78%
18,002,214 $1.07 Billion
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $273 Million - $309 Million
4,201,326 Added 11441.83%
4,238,045 $308 Million
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $39.3 Million - $42.4 Million
-580,425 Reduced 94.05%
36,719 $2.57 Million
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $39.2 Million - $42.8 Million
617,144 New
617,144 $42.5 Million
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $185 Million - $211 Million
-3,082,197 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $53.8 Million - $61.3 Million
949,275 Added 44.51%
3,082,197 $180 Million
Q3 2020

Nov 12, 2020
BUY
$62.1 - $78.08 $9.47 Million - $11.9 Million
152,480 Added 7.7%
2,132,922 $135 Million
Q2 2020

Aug 12, 2020
BUY
$72.34 - $84.0 $63.7 Million - $74 Million
881,065 Added 80.14%
1,980,442 $152 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $43.3 Million - $55.4 Million
-690,815 Reduced 38.59%
1,099,377 $82.2 Million
Q4 2019

Feb 13, 2020
BUY
$61.62 - $67.78 $868,102 - $954,884
14,088 Added 0.79%
1,790,192 $116 Million
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $114 Million - $125 Million
-1,818,029 Reduced 50.58%
1,776,104 $113 Million
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $21.1 Million - $23.7 Million
341,000 Added 10.48%
3,594,133 $243 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $130 Million - $145 Million
2,073,539 Added 175.78%
3,253,133 $211 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $9.27 Million - $12.1 Million
-153,107 Reduced 11.49%
1,179,594 $73.8 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $83.7 Million - $92.7 Million
-1,174,582 Reduced 46.85%
1,332,701 $103 Million
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $43.4 Million - $50.6 Million
-668,464 Reduced 21.05%
2,507,283 $178 Million
Q1 2018

May 14, 2018
BUY
$72.84 - $88.8 $7.68 Million - $9.36 Million
105,420 Added 3.43%
3,175,747 $239 Million
Q4 2017

Feb 09, 2018
BUY
$71.15 - $83.52 $217 Million - $254 Million
3,046,047 Added 12545.5%
3,070,327 $220 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $1.75 Million - $2.08 Million
24,280
24,280 $1.97 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email